Compare VSTM & KBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VSTM | KBON |
|---|---|---|
| Founded | 2010 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.8M | 442.8M |
| IPO Year | 2011 | 2025 |
| Metric | VSTM | KBON |
|---|---|---|
| Price | $7.52 | $10.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 63.4K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,914,000.00 | N/A |
| Revenue This Year | $282.64 | N/A |
| Revenue Next Year | $72.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $3.43 | $10.04 |
| 52 Week High | $10.82 | $10.15 |
| Indicator | VSTM | KBON |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 45.16 |
| Support Level | $6.68 | $10.05 |
| Resistance Level | $7.86 | $10.12 |
| Average True Range (ATR) | 0.41 | 0.00 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 32.79 | 0.00 |
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Karbon Capital Partners Corp is a blank check company.